Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 158.87 | 16.35 |
| PEG Ratio (TTM) | -1.69 | 1.68 |
| P/S Ratio (TTM) | 2.18 | 2.61 |
| P/B Ratio (TTM) | 1.06 | 1.91 |
| P/FCF Ratio (TTM) | -18.46 | 11.19 |
| Price to 5YR AVG Earnings Ratio | 16.49 | 14.05 |
| Price to 5YR AVG FCF Ratio | 5.03 | 8.11 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.07% | 1,504.35% |
| ROE (TTM) | 0.69% | 8.89% |
| Net Profit Margin (TTM) | 1.37% | 15.63% |
| ROIC 5YR AVG | -214.35% | 20.58% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -56.30% | 77.88% | 45.07% |
| Revenue | 10.61% | -3.18% | 2.33% |
| Net Income | -49.27% | 70.31% | 39.75% |
| Cash Flow | -361.06% | 396.09% | 252.67% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.69 | 3.17 |
| Quick Ratio (TTM) | 3.69 | 4.87 |
| D/E Ratio (TTM) | 0.51 | 1.27 |
| Interest Coverage (TTM) | 0.05 | 0.64 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 0.43 | 0.38 |
| LTL to 5YR AVG FCF | 1.22 | 6.38 |
| Shares Outstanding Growth 5YR AVG | -0.74% | 4.83% |